According to the 2021 Restricted Stock Unit Plan, Simcere Pharma (02096) has granted a total of 2.169 million restricted stock units.
Sinopharm Holdings (02096) announced that on March 26, 2026, it approved the grant of a total of 2.169 million restricted stock units (equivalent to 2.169 million shares of the relevant shares) at zero cost under the 2021 Restricted Stock Unit Plan to a total of 54 eligible participants, pending acceptance by the grantees.
SIMCERE PHARMA (02096) announced that on March 26, 2026, it has resolved to grant a total of 2.169 million restricted share units (equivalent to 2.169 million shares of the relevant stock) to a total of 54 eligible participants under the 2021 Restricted Share Units Plan at zero cost, subject to acceptance by the grantee.
Related Articles

KAISA PROSPER (02168) announced its annual performance, with a net profit attributable to shareholders of 13.198 million yuan, a decrease of 9.45% year-on-year.

YIP'S CHEMICAL (00408) announces annual performance, with shareholders' net profit of HK$137 million, a year-on-year increase of 41.8%.

BAIRONG-W(06608) is planning to change its name to "Bairong AI Inc."
KAISA PROSPER (02168) announced its annual performance, with a net profit attributable to shareholders of 13.198 million yuan, a decrease of 9.45% year-on-year.

YIP'S CHEMICAL (00408) announces annual performance, with shareholders' net profit of HK$137 million, a year-on-year increase of 41.8%.

BAIRONG-W(06608) is planning to change its name to "Bairong AI Inc."

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


